Neha Vapiwala (@nehavapiwala) 's Twitter Profile
Neha Vapiwala

@nehavapiwala

Radiation Oncologist, Dean of Admissions, Mother of 3, Cheerleader of many. Views are my own

ID: 1187427134114918401

calendar_today24-10-2019 17:57:49

231 Tweet

1,1K Takipçi

48 Takip Edilen

Shankar Siva (@_shankarsiva) 's Twitter Profile Photo

🧵2/ SABR is a novel treatment for primary #kidneycancer which is non-invasive and has fewer technical limitations than thermal ablation. We tested SABR in a 🦘&🌷phase II trial for primary RCC that was inoperable or high-risk for surgery. The benchmark was 90% control at 1-year.

🧵2/ SABR is a novel treatment for primary #kidneycancer which is non-invasive and has fewer technical limitations than thermal ablation. We tested SABR in a 🦘&🌷phase II trial for primary RCC that was inoperable or high-risk for surgery. The benchmark was 90% control at 1-year.
Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Diligently conducted trial demonstrating #radiotherapy can be a safe & effective tx option for inoperable primary #kidneycancer. Having options matters to #cancer pts - and to all who care for them, regardless of specialty

Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Communities are key to achieving shared goals, regardless of our backgrounds & identities. It’s a privilege to be part of this one. #PCF #HealthEquity UroToday.com

Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Many agree critical questions remain re: clinical value of treating #ProstateCancer seen only on PET. So let’s get some answers & prove that our treatments help #patients more than they hurt ZERO Prostate Cancer UroToday.com

Advanced Prostate Cancer Consensus Conference (@apccc_lugano) 's Twitter Profile Photo

Meet some of the esteemed chairs of #APCCC24, driving forward the conversation in advanced #prostatecancer. Connect with the forefront of oncology leadership. Visit now: apccc.org/apccc-2024/sci… #OncologyLeaders aurelius omlin silke gillessen Derya Tilki, MD Neha Vapiwala neal shore

Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Truly enjoyed chatting w UroToday re this nationwide trial seeking to help us & our #ProstateCancer pts understand the clinical benefit of #PET-directed treatment intensification. Trying to put the horse back before the cart! National Cancer Institute JanssenUS Blue Earth Diagnostics

ECOG-ACRIN Cancer Research Group (@eaonc) 's Twitter Profile Photo

You may be eligible to participate in a #prostatecancer study, EA8191/INDICATE, for patients with post-prostatectomy recurrence. Learn more: bit.ly/ea8191indicate #pcsm #ProstateCancerAware cc: @nehavapiwala

You may be eligible to participate in a #prostatecancer study, EA8191/INDICATE, for patients with post-prostatectomy recurrence. Learn more: bit.ly/ea8191indicate #pcsm #ProstateCancerAware cc: @nehavapiwala
Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Churchill said, "We make a living by what we get, but we make a life by what we give.” Thank you to these 3 incredible colleagues for exemplifying the spirit of these words in their actions - congrats! 🙌🏽

Neha Vapiwala (@nehavapiwala) 's Twitter Profile Photo

Grateful for colleagues Women in Oncology & Healio who serve the entire #cancer community, increasing awareness of safe & effective treatments like #radiationtherapy. Through greater awareness comes greater #patient access. ASCO Jill Feldman